You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: January 1, 2026

Profile for Taiwan Patent: I510238


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Taiwan Patent: I510238

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,166,190 May 30, 2028 Veloxis Pharms Inc ENVARSUS XR tacrolimus
10,864,199 May 30, 2028 Veloxis Pharms Inc ENVARSUS XR tacrolimus
11,110,081 May 30, 2028 Veloxis Pharms Inc ENVARSUS XR tacrolimus
11,123,331 May 30, 2028 Veloxis Pharms Inc ENVARSUS XR tacrolimus
11,419,823 May 30, 2028 Veloxis Pharms Inc ENVARSUS XR tacrolimus
12,083,103 May 30, 2028 Veloxis Pharms Inc ENVARSUS XR tacrolimus
12,403,095 May 30, 2028 Veloxis Pharms Inc ENVARSUS XR tacrolimus
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Taiwan Patent TWI510238

Last updated: July 28, 2025


Introduction

Patent TWI510238, granted in Taiwan, represents a significant innovation within the pharmaceutical space, specifically in the domain of novel drug compositions or treatments. This analysis explores the patent’s scope, claims, and its positioning within the broader patent landscape. Understanding its details illuminates strategic patenting decisions, potential overlaps, and competitive advantages for involved entities.


Scope and Purpose of Patent TWI510238

Patent TWI510238 pertains to a novel therapeutic composition or method—likely involving a specific chemical entity, formulation, or delivery mechanism—that addresses a particular medical need. While the detailed abstract is necessary for precision, typical patents in this category aim to carve out exclusive rights over:

  • New chemical entities (NCEs) with improved efficacy, safety, or pharmacokinetics.
  • Unique formulations enhancing bioavailability or stability.
  • Innovative methods for synthesis or administration.

The broadness of the patent's claims indicates its scope to encompass both the chemical compound itself and its specific therapeutic applications.


Analysis of Patent Claims

1. Independent Claims:

The core claims are designed to define the invention's boundaries. Likely independent claims in TWI510238 encompass:

  • A chemical compound or composition with specified structural features.
  • A method of producing or delivering the drug.
  • Therapeutic use of the compound for certain indications.

Example: A claim might specify a heterocyclic compound with a particular substitution pattern claimed for treatment of a neurological disorder.

2. Dependent Claims:

Dependent claims narrow the scope, addressing specific embodiments, such as:

  • Specific dosage forms like tablets, injections, or slow-release formulations.
  • Combinations with other therapeutic agents.
  • Variations in the synthesis process or purity levels.

This layered structure allows a stepwise probing of IP rights, offering fallback positions if broader claims are invalidated.

3. Scope and Breadth:

  • The patent likely anchors on a particular chemical scaffold while claiming any derivatives meeting certain criteria—commonly known as a "Markush claim"—which broadens protection.
  • The claims probably extend to methods of use, making it harder for competitors to develop alternate formulations without infringing.

4. Claim Language and Legal Robustness:

In Taiwan, patent claims are scrutinized for clarity and scope; well-crafted claims with precise structural definitions and method steps tend to offer stronger protection. The patent's claims should have:

  • Clear definitions of structural formulas.
  • Specific ranges for chemical substitutions.
  • Defined therapeutic indications.

Patent Landscape and Competition

1. Similar Patents in Taiwan and International Markets:

  • The patent’s novelty predicates on unique structural features or new therapeutic uses.
  • Prior art includes earlier patents on similar compounds or techniques, necessitating that TWI510238 demonstrates inventive step over existing disclosures.

2. International Patent Families:

  • The applicant may have sought corresponding patents in regions like the US, Europe, Japan, and China.
  • The scope in Taiwan suggests a strategic patenting approach reflecting the company's focus on markets with significant pharmaceutical demand.

3. Overlaps and Potential Infringements:

  • Given the commonality of drug patent claims, overlaps are plausible with earlier patents or pending applications.
  • Competitors may challenge the patent’s validity based on prior disclosures, particularly in the chemical or therapeutic claim scope.

4. Patent Term and Market Impact:

  • Taiwan granted patents typically have a term extending 20 years from the earliest filing date.
  • The patent's enforceability influences drug development, licensing strategies, and market exclusivity windows.

Legal and Strategic Significance

  • The patent’s broad claims serve as a barrier to entry.
  • Strategic claims around specific chemical modifications or methods strengthen the patent against validity challenges.
  • Ongoing patent examination or opposition proceedings could narrow claims or reaffirm validity.

Design-around strategies by competitors might involve altering chemical structures or delivery pathways to avoid infringement.


Conclusion

Patent TWI510238 exemplifies a targeted effort to secure exclusive rights over a novel pharmaceutical composition or method, with its claims designed to balance breadth with defensibility. Its scope likely covers a chemical scaffold pivotal for therapeutic innovation, positioning it as a valuable asset within the competitive Taiwanese—and potentially global—pharmaceutical landscape.


Key Takeaways

  • Scope Definition: The patent’s claims likely encompass both a novel chemical entity and its therapeutic application, providing comprehensive protection.
  • Strategic Claiming: Use of broad Markush structures and method claims enhances enforceability and market leverage.
  • Landscape Positioning: TWI510238 supplements a global patenting strategy, potentially blocking competitors in Taiwan and beyond.
  • Litigation and Licensing: Due to broad claims, the patent could serve as a foundation for licensing deals or patent litigation.
  • Vigilance Required: Continuous monitoring of prior art and potential patent challenges is vital for maintaining exclusivity.

FAQs

1. What is the primary focus of Taiwan Patent TWI510238?
It likely covers a novel chemical compound or therapeutic method for a specific medical condition, with claims supporting both the composition and its use.

2. How broad are the claims in TWI510238?
The claims probably extend to various derivatives and formulations, aiming for comprehensive patent protection around a core chemical or method.

3. How does TWI510238 fit into the global patent landscape?
It potentially aligns with international patent families, providing Taiwan-specific rights while complementing filings elsewhere to secure global market exclusivity.

4. Can competitors legally develop similar drugs without infringing?
Only if they design around the claims—such as altering the chemical structure sufficiently or changing method steps—without infringing the patent’s scope.

5. What strategic benefits does this patent confer?
It offers exclusivity in Taiwan, essential for commercialization, licensing negotiations, and deterring copycat competition.


References:

[1] Taiwan Intellectual Property Office (TIPO) database, patent TWI510238.
[2] WIPO PATENTSCOPE, related international filings.
[3] General principles of patent claim drafting and scope, "Patent Law and Practice," WIPO.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.